Posted in | News

Masisa’s Door Manufacturing Operations to be Acquired by Masonite

Masonite International Corporation (the “Company”) today announced it has signed a definitive agreement to acquire the door manufacturing operations of Masisa S.A. for approximately $12.5 million. The transaction includes the door component operations in Cabrero, Chile and a door assembly factory in Chillan, Chile.

The operations to be acquired primarily manufacture high quality stile and rail panel and French wood doors for the North American market. The facilities employ approximately 300 people.

“The addition of this manufacturing capability to our existing stile and rail wood door offering in North America will help ensure that our customers have reliable access to the widest range of high quality, cost effective wood door products.” stated Chris Virostek, Masonite’s Senior Vice President of Corporate Development. “This transaction complements our existing residential wood door offering and provides an important additional platform of strategic growth for our company.”

“We are pleased to enter into this transaction with Masonite and believe it is a very good fit for the customers, employees and suppliers of the door business” said Jaime Valenzuela, Masisa Andina General Manager.

The transaction is expected to close within the next 30 days, subject to customary closing conditions.

This press release is available on the Company's website at www.masonite.com.

About Masonite

Masonite International Corporation is a leading global designer and manufacturer of interior and exterior doors for the residential new construction; the residential repair, renovation and remodeling; and the non-residential building construction markets. Since 1925, Masonite has provided its customers with innovative products and superior service at compelling values. Masonite currently serves more than 6,000 customers in 70 countries.

Source: http://www.masonite.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.